INNATE PHARMA earnings per share and revenue

4IPH earnings per share for the last semiannual are -0.31 EUR whereas the estimation was -0.28 EUR which accounts for -10.71% surprise. Company revenue for the same period amounts to 12.35 M EUR despite the estimated figure of 12.40 M EUR. Estimated earnings per share for the next semiannual are -0.26 EUR, and revenue is expected to reach 17.29 M EUR. Also watch annual changes over time to get a bigger picture of 4IPH earnings per share and revenue dynamics.